Arecor Therapeutics plc (AREC.L) LSE

71.24

+0.74(+1.05%)

Updated at September 08 01:17PM

Currency In GBp

Valuation

Market Cap24.58M
Enterprise Value21.57M
P/E Ratio-2.63
PEG Ratio0.37
Price/Sales Ratio5.32
Price/Book Ratio5.03
Enterprise/Revenue4.73
Enterprise/EBITDA-2.35

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-2.03
Operating Margin-1.51

Management Effectiveness

Return On Assets-1.17
Return On Equity-1.96

Income Statement

Revenue5.05M
Revenue/Share0.13
Gross Profit1.54M
EBITDA-10.15M
Net Income-10.24M
Diluted EPS-0.33

Balance Sheet

Total Cash3.26M
Total Cash/Share0.09
Total Debt232,000
Total Debt/Equity0.04
Current Ratio2.53
Book Value Per Share0.14

Price History

52-Week Change-8.08
52-Week High80.24
52-Week Low35.4
Moving Average 50 Days56.6
Moving Average 200 Days52.98

Statistics

Average Volume53,206
Shares Outstanding37.76M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A